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Abstract: Mitochondrial dysfunction has been associated with obesity-related muscle insulin 
resistance, but the causality of this association is controversial. The notion that mitochondrial 
oxidative capacity may be insufficient to deal appropriately with excessive nutrient loads is 
for example disputed. Effective mitochondrial capacity is indirectly, but largely determined by 
ATP-consuming processes because skeletal muscle energy metabolism is mostly controlled 
by ATP demand. Probing the bioenergetics of rat and human myoblasts in real time we show 
here that the saturated fatty acid palmitate lowers the rate and coupling efficiency of 
oxidative phosphorylation under conditions it causes insulin resistance. Stearate affects the 
bioenergetic parameters similarly, whereas oleate and linoleate tend to decrease the rate but 
not the efficiency of ATP synthesis. Importantly, we reveal that palmitate influences how 
oxidative ATP supply is used to fuel ATP-consuming processes. Direct measurement of 
newly made protein demonstrates that palmitate lowers the rate of de novo protein synthesis 
by more than 30%. The anticipated decrease of energy demand linked to protein synthesis is 
confirmed by attenuated cycloheximide-sensitivity of mitochondrial respiratory activity used 
to make ATP. This indirect measure of ATP turnover indicates that palmitate lowers ATP 
supply reserved for protein synthesis by at least 40%. This decrease is also provoked by 
stearate, oleate and linoleate, albeit to a lesser extent. Moreover, palmitate lowers ATP 
supply for sodium pump activity by 60-70% and, in human cells, decreases ATP supply for 
DNA/RNA synthesis by almost three-quarters. These novel fatty acid effects on energy 
expenditure inform the „mitochondrial insufficiency‟ debate. 
Keywords: palmitate-induced insulin resistance, skeletal muscle, mitochondrial dysfunction, 
ATP turnover, obesity, type 2 diabetes  
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1. INTRODUCTION 
Obesity and insulin resistance are related features of the Metabolic Syndrome, a cluster of 
medical disorders that increase the risk of developing type 2 diabetes and cardiovascular 
disease [1]. Increased insulin secretion by the pancreatic beta cells may compensate insulin 
resistance of skeletal muscle and the liver initially, but the obese state often also provokes 
beta cell dysfunction [2], which largely accounts for the persistently high blood glucose level 
that characterises type 2 diabetes [3]. The molecular mechanisms that link obesity to insulin 
resistance are yet to be established conclusively but likely involve excess dietary nutrients, 
peptide hormones and inflammatory molecules [4]. Non-esterified fatty acids (NEFAs1) are 
for example relatively abundant in the circulation of obese subjects [5], and exposure of 
skeletal muscle and myocytes to free fatty acids – saturated long-chain species such as 
palmitate and stearate in particular – causes insulin resistance [6]. 
The mechanism by which free fatty acids dampen the insulin sensitivity of skeletal muscle is 
not fully understood, but NEFA-induced insulin resistance has been associated firmly with 
mitochondrial dysfunction [7-9]. However, the causality of this association remains subject of 
fierce debate [10,11]. It is highly conceivable that the oxidative capacity of muscle cells in 
obese subjects is insufficient to burn the elevated NEFA supply effectively [7,12] and thus 
causes accumulation of metabolites that blunt insulin responsiveness. Molecules suggested 
to interfere with insulin signalling include lipid species such as ceramide and diacylglycerol 
[13,14], and mitochondrial reactive oxygen species (ROS) [15-17]. Despite experimental 
evidence in its favour [10], the „mitochondrial insufficiency‟ model does not enjoy unanimous 
support [8,11]. Various rodent models of severe mitochondrial dysfunction for example 
exhibit improved rather than impaired muscle insulin sensitivity [18-20], and fat oxidation 
capacity tends to be increased, not decreased, in obese/insulin-resistant and type 2 diabetic 
subjects [11]. Moreover, type 2 diabetic patients increase their substrate oxidation rate some 
40-fold in response to exercise [11]. Based on this sizeable response, it has been reasoned 
[11] that obese subjects should have enough spare respiratory capacity to fully oxidise any 
excess lipid. 
The capacity of a biological system to burn metabolic fuel depends on the way it controls its 
energy metabolism. Arguably the most important parameter in cellular bioenergetics is the 
                                               
1  Abbreviations: AHA, L-azidohomoalanin; 2DG, 2-deoxyglucose; BSA, bovine serum 
albumin; DMEM, Dulbecco‟s modified Eagle medium; FCCP, trifluorocarbonylcyanide 
phenylhydrazone; FBS, fetal bovine serum; Hepes, 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid; KRPH, Krebs Ringer Phosphate Hepes buffer; NEFA, non-esterified fatty acid; 
PBS, phosphate-buffered saline; RFU, relative fluorescence units; ROS, reactive oxygen 
species 
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ATP/ADP ratio, as it is this phosphorylation potential that allow cells to perform work [21]. In 
muscle cells, the ATP/ADP ratio is mostly controlled by ATP demand, a paradigm [21] that is 
acknowledged by both proponents and opponents of the „mitochondrial insufficiency‟ model 
[10,11]. Such distribution of control implies that the rate of ATP supply, and hence oxidative 
phosphorylation, is fully governed by ATP turnover. In other words, any spare respiratory 
capacity of a muscle cell will be inconsequential if there is no demand for ATP. Indeed, many 
paradoxical observations in the insulin resistance literature are readily reconciled by 
considering the variable energetic needs of the different experimental systems studied [8]. 
As cellular energy demand clearly influences how lipids affect insulin sensitivity [8], we 
deemed it important to establish whether or not NEFA exposure had any effect on the ATP 
requirements of skeletal muscle cells. 
In this paper we report that palmitate-induced insulin resistance of rat and human skeletal 
muscle cells associates with a decreased rate and efficiency of oxidative phosphorylation, 
and, importantly, with an inhibition of major ATP-consuming processes. These data suggest 
that the lowered ATP supply is partly owing to decreased ATP turnover. 
 
 
2. MATERIAL AND METHODS 
2.1 Cell culture 
Rat L6 myoblasts were obtained from the European Collection of Cell Culture and were 
maintained at 37 ºC under a humidified carbogen atmosphere in Dulbecco‟s Modified Eagle 
Medium (DMEM – LifeTechnology 42430-025) containing 25 mM glucose and 20 mM Hepes 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and supplemented with 10% (v/v) FBS 
(fetal bovine serum), 100 U/mL penicillin, and 100 µg/mL streptomycin. Cells between 
passages 18 and 25 were used for experimentation. As described in detail before [22], 
human myoblasts were isolated and cultured at the University of Exeter Medical School, St 
Luke‟s Campus (Human Tissue Authority licence 12104), and passaged at least twice before 
off-site analysis. Needle biopsies to remove skeletal muscle (vastus lateralis) tissue were 
taken with informed donor consent and with approval from the Ethics Committee of the 
Department of Sport and Health Sciences, College of Life and Environmental Sciences, 
University of Exeter, UK. Human muscle cells were maintained at 37 ºC under a humidified 
carbogen atmosphere in DMEM (Life Technology 22320-22) containing 5 mM glucose and 
20 mM Hepes  and supplemented with 20% (v/v) FBS, 0.5% (v/v) chick embryo extract, 2 
nM insulin, 100 U/mL penicillin, and 100 μg/mL streptomycin. The initial cell population was 
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allowed to double 4x before experimentation, and all assays were performed before the 
population had doubled 10x. 
2.2 Fatty acids 
Prior to NEFA exposure, cells were nutrient-restricted for 10 or 24 h (glucose uptake and 
cellular bioenergetics assays, respectively) in DMEM (Life Technology 22320-22) containing 
just 5 mM glucose and supplemented with only 2% (v/v) FBS to sensitise the cells to insulin 
[22,23]. NEFAs were administered in conjugation to fatty-acid-free bovine serum albumin 
(BSA – Sigma A7030) as described previously [22], and cells were exposed to BSA-
conjugated NEFAs or to BSA alone for 16 h in DMEM (Life Technology 22320-22) without 
added FBS. NEFA:BSA conjugates were applied at molar ratios to yield estimated free 
NEFA levels of approximately 20 nM [24]. 
2.3 Insulin resistance 
Insulin sensitivity was measured as the response of 2-deoxyglucose (2DG) uptake to 100 
nM insulin as described previously [22]. The estimated free palmitate concentration of 20 nM 
rendered both L6 and human myoblasts insensitive to insulin following 16-h exposure (Fig. 
2B) but did not cause significant cell loss (not shown). 
2.4 Protein synthesis 
The rate of de novo protein synthesis was determined by tagging newly synthesised proteins 
with L-azidohomoalanine (Click-iT® AHA, Invitrogen C10102) as published by others [25]. In 
essence, L6 myoblasts were cultured in 25-cm2 flasks to approximately 60% confluency and 
then exposed to BSA-conjugated palmitate or BSA alone for 16 h. Cells were washed twice 
with methionine-free DMEM (Invitrogen 21013) supplemented with 2 mM L-glutamine and 1 
mM sodium pyruvate, and incubated in this medium for 1 h at 37 ˚C under carbogen. After 
this methionine depletion, 25 µM AHA was added and cells were incubated for another 4 h. 
Cells were harvested by trypsinisation in 1 mL phosphate-buffered saline (PBS) containing 3% 
(w/v) BSA. After passing cells in this „flow medium‟ through a 35-µM cell strainer (Fisher 
Scientific 08-771-23) they were harvested by centrifugation in 500 µL PBS containing 0.05% 
(v/v) Triton X-100. After 2-min incubation, permeabilised cells were washed once with flow 
medium and resuspended in 500 µL Click-iT® cell reaction buffer that was supplemented 
with CuSO4 and proprietary additives according to the manufacturer‟s instructions (Invitrogen 
C10269) and with 3 µM Alexa Fluor® 488 alkyne (Invitrogen A10267). Cells were incubated 
for 30 min at room temperature to allow chemoselective ligation between the green-
fluorescent alkyne probe and the azido-modified protein. After this, cells were washed once 
with flow medium and analysed by flow cytometry using a BD FACSAria™ II cell sorter. 
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2.5 Cellular bioenergetics 
2.5.1 Oxygen consumption 
Mitochondrial respiratory activity was measured in attached cells as described before [26]. 
Briefly, L6 myoblasts seeded at 4 x 104 cells per well and exposed to palmitate on XF24 
tissue culture plates (Seahorse Bioscience) were washed 4x with a Krebs Ringer Phospate 
Hepes buffer (KRPH) comprising 136 mM NaCl, 3.7 mM KCl, 10 mM Hepes, (pH 7.4), 2 mM 
NaH2PO4, 1 mM MgCl2, 1.5 mM CaCl2, and 0.1% (w/v) BSA, and were then incubated in this 
buffer for 1 h at 37 ºC under air. Human myoblasts were treated similarly, but were seeded at 
2-3 x 104 cells per well, and were not washed into KRPH, but into serum-free DMEM 
containing 2 mM glucose and 10 mM Hepes. Subsequently, the plates were transferred to a 
Seahorse XF24 extracellular flux analyser (controlled at 37 ˚C) for a 10-min calibration after 
which cellular oxygen consumption was recorded under various conditions to determine both 
ATP supply and ATP demand (Fig. 1). 
 
Fig. 1 – Skeletal muscle bioenergetics. 
The ATP/ADP ratio in skeletal muscle cells 
is controlled by ATP demand: changes in 
ATP-consuming processes are countered by 
proportional changes in ATP supply. Under 
aerobic conditions, ATP is mainly supplied 
by oxidative phosphorylation. Mitochondrial 
substrate oxidation (measured as rotenone-
and-antimycin-A-(Rot/AA)-sensitive oxygen 
uptake) builds a protonmotive force (pmf) 
across the mitochondrial inner membrane 
that is either used to make ATP (oligomycin-
sensitive oxygen uptake) or is dissipated by 
proton leak (oligomycin-insensitive oxygen 
uptake). FCCP renders membranes proton-
permeable. Protein synthesis, DNA/RNA 
synthesis and Na
+
 pump activity are ATP-
demanding processes that account for about 
two-thirds of total ATP turnover in L6 and 
human myoblasts (Figs 6C and 6D). These 
processes are inhibited by cycloheximide, 
actinomycin D and ouabain, respectively. 
 
2.5.2 ATP supply  
Following Seahorse measurement of basal cellular respiration [26], oligomycin (5 µg/mL), 
FCCP (trifluorocarbonylcyanide phenylhydrazone – 2 µM and 20 µM for human and L6 cells, 
respectively), and a mixture of rotenone (1 µM) and antimycin A (2 µM) were added 
sequentially to inhibit the ATP synthase, uncouple oxidative phosphorylation, and to 
determine non-mitochondrial respiration, respectively  (Fig. 1). Non-mitochondrial respiratory 
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activity was subtracted from all other activities to calculate bioenergetic parameters 
concerning mitochondrial ATP supply. Cellular respiratory control was calculated as the ratio 
of FCCP-stimulated and oligomycin-inhibited respiratory rates [27], and coupling efficiency of 
oxidative phosphorylation was defined as the oligomycin-sensitive part of mitochondrial 
respiration, i.e., the respiratory proportion that is used to make ATP [27]. Respiration was 
normalised to cell density derived from DAPI fluorescence [28] to calculate absolute oxygen 
uptake. Absolute oligomycin-sensitive oxygen consumption rates were converted to ATP 
supply rates assuming P/O ratios of 2.41 and 2.10 for glucose and palmitate oxidation, 
respectively [29]. 
2.5.3 ATP demand 
In systems where the ATP/ADP ratio is fully controlled by ATP demand, the activity of an 
ATP-demanding process may be approximated from the change in oligomycin-sensitive 
mitochondrial respiratory activity that is seen upon specific inhibition of that process  [30,31]. 
Cycloheximide (40 µM), actinomycin D (10 µM) and ouabain (380 µM) were applied to 
estimate how much ATP supply flux was allocated to fuel, respectively, protein synthesis, 
DNA and RNA synthesis, and sodium pump (Na+/K+-ATPase) activity (Fig. 1). The stated 
inhibitor levels were selected empirically as the lowest concentrations that exerted saturating 
inhibitory effects on basal mitochondrial respiration without significantly affecting the FCCP-
uncoupled respiration. 
2.6 Statistics 
Mean differences were tested for statistical significance by ANOVA, applying Fisher‟s LSD 
multiple comparison post-hoc analysis, using SPSS v17 (IBM) and Stat Graphics Plus v5.1 
(Statistical Graphics Corporation) software. 
 
 
Fig. 2 – Palmitate-induced insulin resistance. Panel A: 2DG uptake was measured in L6 (circles) 
and human (triangles) myoblasts in the absence (white symbols) or the presence of 100 nM insulin 
(black symbols) as described before [22]. The differences between insulin-exposed and control cells 
are statistically significant (P < 0.05) at applied 2DG levels of 600 and 1000 ng/well. Panel B: 2DG 
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uptake was measured at 30 mg/well in the absence and presence of 100 nM insulin (white and black 
bars, respectively) in myoblasts exposed to palmitate (PA) or BSA as described in section 2.2. 
*Differs significantly (P<0.05) from the equivalent condition minus insulin. Data are means ± SEM of 3 
independent experiments. 
3. RESULTS 
3.1 Palmitate lowers protein synthesis rate  
To examine NEFA effects on the energy metabolism of skeletal muscle cells, myoblasts 
were exposed to palmitate at a dose and exposure time (Material and Methods) that caused 
insulin resistance (Fig. 2). Control myoblasts respond acutely to insulin as reflected by the 
stimulatory effect of insulin on dose-dependent 2DG accumulation by L6 and human cells 
(Fig. 2A). This responsiveness is unaffected when cells are exposed to BSA, but is fully 
annulled upon exposure to BSA-conjugated palmitate (Fig. 2B). 
To explore if the insulin-numbing palmitate exposure is in any way associated with changes 
in skeletal muscle energy demand, we measured the rate at which L6 cells make protein, a 
process that represents a significant source of ATP consumption in muscle and other cells 
[30,32]. Figs 3A and 3B show typical flow cytometry experiments quantifying fluorescence 
exhibited by control and palmitate-exposed cells, respectively, following 4-h incubation with 
AHA and subsequent treatment with ALEXA Fluor® 488 alkyne. Control myoblasts clearly 
contain newly synthesised (AHA-labelled) protein as is reflected by 2 distinct cell populations 
with median fluorescence values of approximately 8,000 and 20,000 RFU (relative 
fluorescence units), respectively (Fig. 3A). Fluorescence of cells not exposed to AHA was 
below 200 RFU (not shown). Palmitate increases the median frequency of the „low-
fluorescence‟ population from about 250 to 300 counts and decreases the median „high-
fluorescence‟ frequency from 120 to 60 counts (Fig. 3B). Consequently, the average 
fluorescence intensity of palmitate-exposed cells is lower than that of control cells (Fig. 3C – 
12,500 versus 18,500 RFU), which demonstrates that palmitate has lowered the rate of de 
novo protein synthesis by more than 30%. 
 
 
Fig. 3 – Palmitate lowers de novo protein synthesis. Control (Panel A) and palmitate-exposed 
(Panel B) L6 myoblasts incubated with AHA for 4 h and then treated with ALEXA Fluor® 488 alkyne 
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were analysed by flow cytometry (10,000 counts per run) applying a excitation/ emission wavelength 
filter of 495/519 nm. Panel C: average fluorescence intensity of cells exposed to BSA or palmitate 
(PA). Data are means ± SEM of 4 exposures. *Differs significantly (P < 0.05) from the BSA control. 
 
 
Fig. 4 – Palmitate lowers the rate and efficiency of myoblast ATP synthesis. Panel A: typical 
respiratory traces showing oxygen uptake by L6 (circles) and human (triangles) myoblasts exposed to 
palmitate (black symbols) or BSA (white symbols). These traces were used as controls in preliminary 
ATP-demand assays (Fig. 5), which is why buffer was added before oligomycin (OLI), FCCP and 
rotenone/antimycin A (R/A). Traces were obtained from 1 Seahorse run and are means ± SEM of 3-4 
wells per condition. Cell respiratory control (Panel B), coupling efficiency of oxidative phosphorylation 
(Panel C) and the absolute rate of ATP supply (Panel D) were derived as described in the text. Data 
are means ± SEM of 10 experiments. *Differs significantly (P<0.05) from the equivalent BSA control. 
3.2 Palmitate lowers the rate and efficiency of ATP supply 
Inhibition of protein synthesis by palmitate (Fig. 3) is expected to change mitochondrial ATP 
supply, because protein synthesis is a major energy-demanding process in muscle cells [32] 
and because muscle energy metabolism is predominantly controlled by ATP demand [21]. 
Respiratory analysis reveals that palmitate-induced insulin resistance indeed coincides with 
statistically significant changes in oxidative phosphorylation (Fig. 4). Basal cellular oxygen 
consumption in control cells is inhibited considerably by oligomycin, subsequently stimulated 
by FCCP, and then almost abolished by antimycin A and rotenone (Fig. 4A). At first glance, 
these typical respiratory responses are not drastically different in palmitate-exposed cells, 
although FCCP stimulation of respiration appears attenuated in human myoblasts (Fig. 4A). 
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Indeed, the apparent palmitate effect on FCCP-uncoupled respiration is reflected by a 
decreased cell respiratory control ratio [27] in human myoblasts (Fig. 4B). Palmitate 
exposure also lowers respiratory control in L6 cells, but not to a statistically significant extent 
(Fig. 4B). In addition, palmitate lowers coupling efficiency of oxidative phosphorylation in 
human and L6 myoblasts (Fig. 4C), i.e., it decreases the fraction of respiration that is used to 
make ATP. Absolute ATP synthesis flux is readily derived from oligomycin-sensitive oxygen 
uptake by normalising it to cell number and multiplying it by P/O. Assuming control cells are 
fuelled by endogenous glucose (i.e., the sole carbon source fuelling the cells during growth) 
we used a P/O ratio of 2.41 [29] and calculated that rat and human myoblasts make about 
150 pmol ATP per min per 40,000 cells (Fig. 4D). Skeletal muscle suppresses glucose 
catabolism when lipid is available [33], so using a P/O ratio of 2.10 [29] we established that 
palmitate lowers the ATP supply rate in both systems to approximately 120 pmol ATP per 
min per 40,000 cells (Fig. 4D). 
 
 
Fig. 5 – Palmitate lowers the proportion of ATP supply allocated to protein synthesis. Typical 
respiratory traces showing oxygen consumption by L6 (Panel A) and human (Panel B) myoblasts 
grown in fully supplemented DMEM (specified in section 2.1). Buffer (BUF – black circles) or 40 µM 
cycloheximide (CHX – white triangles) was added before sequential injection of oligomycin (OLI), 
FCCP and a mix of rotenone and antimycin A (R/A). Traces were obtained from 1 Seahorse run and 
are means ± SEM of 3-4 wells per condition. Cell respiratory control ratios (Panel C – cf. Material and 
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Methods) are means ± SEM of 3 experiments with L6 (white bars) or human (black bars) myoblasts 
grown in serum-depleted medium containing BSA (cf. section 2.2). Sensitivity of basal mitochondrial 
respiration to cycloheximide (Panel D – CHX) was expressed as a fraction of total oligomycin-
sensitive respiratory activity. Data are means ± SEM of 3 experiments with L6 or human myoblasts 
grown in fully supplemented (cf. section 2.1) DMEM (black bars) or in serum-depleted medium with 
BSA or BSA-conjugated palmitate (white and shaded bars, respectively). *Differs significantly (P<0.05) 
from the equivalent BSA control. 
3.3 Palmitate lowers ATP supply reserved for protein synthesis 
A decreased rate of oxidative phosphorylation (Fig. 4) is consistent with palmitate inhibition 
of protein synthesis (Fig. 3) as lowering ATP supply would be a plausible myoblast response 
to attenuated energy demand. Indeed, inhibiting ATP turnover will acutely lower oligomycin-
sensitive respiratory activity of any cell that controls its energy metabolism predominantly by 
ATP demand [30,31].  Figs 5A and 5B for example demonstrate that 40 µM cycloheximide 
causes an instant and stable decrease of basal respiration in both L6 and human myoblasts. 
Oligomycin lowers respiration further and allows the cycloheximide-induced decrease to be 
normalised to ATP-synthesis-coupled oxygen uptake (Fig. 5D – DMEM). FCCP uncouples 
respiration from ATP synthesis and confirms that the respiratory decrease is secondary to 
lowered ATP demand and not to direct inhibition of mitochondrial electron transfer. At a 
concentration that does not affect the cell respiratory control ratio (Fig. 5C), cycloheximide 
lowers oligomycin-sensitive respiration by about 35% (Fig. 5D), which indicates that L6 and 
human cells use one-third of their total ATP supply to drive protein synthesis. BSA tends to 
lower cycloheximide sensitivity marginally, but palmitate decreases it significantly to ~ 20% 
of total respiration linked to ATP synthesis (Fig. 5D). Consistent with measurement of newly 
made protein (Fig. 3C), palmitate lowers ATP supply reserved for protein synthesis (Fig. 5D). 
In a separate set of experiments we also exposed L6 myoblasts to stearate, a saturated fatty 
acid 2 carbon atoms longer than palmitate, and to oleate and linoleate, the monounsaturated 
and polyunsaturated counterparts of stearate, respectively. Probably owing to different cell 
passage number and subtle differences in experimental conditions, coupling efficiency (Fig. 
6A) and absolute rate of oxidative phosphorylation (Fig. 6B) in BSA-exposed myoblasts were 
a little higher than those observed before (Figs 4C and 4D+7D, respectively). Reassuringly, 
however, these independent results confirm that palmitate significantly lowers the efficiency 
(Fig. 6A) and the rate (Fig. 6B) of mitochondrial ATP synthesis. Stearate has the same effect 
on these parameters as palmitate (Figs 6A and 6B). Oleate and linoleate, on the other hand, 
only tend to lower the ATP synthesis rate (Fig. 6B) and have not effect on coupling efficiency 
(Fig. 6A). Stearate and linoleate significantly lower cycloheximide sensitivity of mitochondrial 
respiration linked to ATP synthesis, but less so than palmitate (Fig. 6C). The small negative 
effect of oleate on cycloheximide sensitivity is not statistically significant. All NEFAs lower 
the absolute ATP supply flux reserved for protein synthesis (calculated by multiplying the 
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cycloheximide-sensitive respiration by P/O – see section 3.2), although the effects of oleate 
and linoleate do not reach statistical significance. 
 
 
Fig. 6 – Effects of saturated and unsaturated NEFAs on ATP synthesis and ATP turnover in L6 
myoblasts. Coupling efficiency of oxidative phosphorylation (Panel A), the rate of total mitochondrial 
ATP synthesis (Panel B), cycloheximide (CHX) sensitivity of respiration coupled to ATP synthesis 
(Panel C) and the absolute ATP supply rate used to fuel protein synthesis (Panel D) were derived as 
described in the text. Data are means ± SEM of 4 experiments. *Differs significantly (P<0.05) from the 
equivalent BSA control. 
3.4 Palmitate causes reallocation of ATP supply 
The close agreement between direct (Fig. 3) and indirect (Fig. 5) measurement of palmitate 
inhibition of myoblast protein synthesis strongly supports the notion that ATP turnover rates 
can be derived accurately from mitochondrial respiratory analysis [30,31]. Therefore, we also 
measured ATP supply used for DNA/RNA synthesis and sodium pump activity by quantifying 
drops in oxygen uptake seen after inhibition of these ATP-consuming processes with 10 µM 
actinomycin D and 380 µM ouabain, respectively. Similar to cycloheximide, actinomycin D 
and ouabain inhibit oligomycin-sensitive oxygen uptake without significant effect on FCCP-
uncoupled respiration (not shown). Normalising inhibitor-sensitive respiration to cell number 
and multiplying it by P/O (cf. section 3.2) yields the absolute ATP supply flux allocated to the 
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respective processes (Fig. 7). On average, rat myoblasts use 47, 31 and 26 pmol ATP per 
min per 40,000 cells to, respectively, fuel protein synthesis, sodium pump activity and 
DNA/RNA synthesis (Fig. 7A). ATP supply reserved by human cells for protein and 
DNA/RNA synthesis is similar to that allocated by their rat counterparts, but human 
myoblasts use comparably little ATP (18 pmol per min per 40,000 cells) to drive the sodium 
pump (Fig. 7B). Given a total ATP supply of 150 pmol ATP per min per 40,000 cells in this 
set of experiments (Fig. 4D), it transpires that ~ 70% and 60% of this supply is used by rat 
and human cells, respectively, to fuel the sum of protein synthesis, DNA/RNA synthesis and 
sodium pump activity (Figs 7C and 7D); the remaining 30-40% drives processes we have not 
assessed and thus remains unaccounted. 
 
 
Fig. 7 – Palmitate reallocates ATP supply. Absolute ATP supply rates (JATP) were calculated as 
described in the main text in L6 (Panels A and C) and human (Panels B and D) myoblasts exposed to 
palmitate (white bars) or BSA (black bars). Oligomycin-sensitive respiration inhibited by cycloheximide, 
ouabain or actinomycin D was used to calculate ATP supply reserved for protein synthesis, sodium 
pump activity and DNA/RNA synthesis, respectively. Data are means ± SEM of 4-6 experiments. 
*Differs significantly (P<0.05) from the equivalent BSA control. Panels C and D: average ATP supply 
fluxes for protein synthesis (black boxes), sodium pump activity (white boxes), DNA/RNA synthesis 
(grey boxes) are the same as those shown in Panels A and B, respectively. The sum of these fluxes 
was subtracted from total ATP supply (Fig. 4D) to derive unaccounted ATP demand (shaded boxes).  
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Palmitate significantly lowers ATP supply for protein synthesis, to about 28 and 24 pmol per 
min per 40,000 cells in rat and human muscle myoblasts, respectively (Fig. 7). The palmitate 
effect on absolute ATP supply is a little more pronounced (40-50% inhibition) than its effect 
on the cycloheximide sensitivity of mitochondrial respiration (Fig. 5D – 33% inhibition), which 
is owing to the different P/O ratios we used for palmitate-exposed and control cells (section 
3.1). Palmitate lowers ATP supply for sodium pump activity by 60-70% and for human (but 
not rat) DNA/RNA synthesis by almost three-quarters (Fig. 7B). Since the palmitate effect on 
total ATP supply is lower than its cumulative effect on ATP turnover, palmitate increases the 
percentage of unaccounted ATP supply in rat (Fig. 7C) and human (Fig. 7D) myoblasts. 
4. DISCUSSION 
The results reported in this paper reveal that palmitate alters mitochondrial ATP supply and 
ATP expenditure in rat and human myoblasts (Fig. 8). The data demonstrate that palmitate 
lowers both the rate and efficiency of ATP supply in these cells (Figs 4 and 6) and, 
importantly, changes how this supply is allocated between ATP-consuming processes (Fig. 
7). Our finding that palmitate and other NEFAs (Fig. 6) remodel ATP turnover is relevant for 
the causality debate as to mitochondrial involvement in obesity-related insulin resistance. 
 
Fig. 8 – Palmitate remodels skeletal muscle bioenergetics. Mitochondrial ATP supply defects 
emerge directly from harmful palmitate effects on fuel combustion or indirectly from effects on ATP 
turnover. 
4.1 Measurement of ATP demand 
ATP turnover measurement from decreases in oligomycin-sensitive respiration provoked by 
inhibition of ATP-consuming processes ([30,31], Fig. 5) requires careful experimental design. 
Comparison between direct and indirect protein synthesis measurement for example reveals 
that ATP supply allocated to this process may readily be overestimated when derived from 
cycloheximide-sensitive respiration [34]. Overestimation depends on cycloheximide level [34] 
and thus likely emerges from nonspecific inhibition of fuel oxidation. Such off-site catabolic 
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effects of ATP demand inhibitors are expected to decrease respiration even when oxygen 
uptake is uncoupled from ATP synthesis with FCCP, so they would lower cell respiratory 
control ratios. At the concentrations we applied, cycloheximide, actinomycin D and ouabain 
did not lower cellular respiratory control, suggesting that inhibition of oligomycin-sensitive 
oxygen uptake by these compounds was only achieved indirectly via their effect on ATP 
turnover. Initial experiments indicated that these compounds indeed inhibit FCCP-uncoupled 
respiration when applied at higher levels (not shown). Direct amino acid incorporation 
measurements show that 25 µM cycloheximide suffices to inhibit protein synthesis [34]. The 
40 µM used here is of the same order of magnitude and provokes an instant and relatively 
stable inhibition (Figs 5A and 5B) that suggests a lack of secondary effects within the 
timescale of our assay. Importantly, cycloheximide sensitivity of coupled mitochondrial 
respiration is decreased by one-third when L6 myoblasts are exposed to palmitate (Fig. 5D), 
i.e., by a magnitude that is identical to the palmitate effect on the protein synthesis rate of 
these cells (Fig. 3C). This close quantitative agreement between direct and indirect 
determination of the palmitate effect on protein synthesis strengthens our confidence in the 
validity of indirect ATP demand measurement. 
4.2 Mechanistic considerations 
Palmitate lowers coupling efficiency of oxidative phosphorylation (Figs 4C and 6A) and 
provokes reallocation of ATP supply (Fig. 7) by mechanisms that are presently unclear. The 
coupling efficiency phenotype likely results from palmitate effects on the proton conductance 
of phospholipid bilayers [35,36]. Palmitate is for example known to induce transient pores in 
the mitochondrial inner membrane [37,38] that will increase proton leak and thus lower the 
proportion of respiration linked to ATP synthesis. The palmitate effect on coupling efficiency 
is arguably small, but it is worth notice in this respect that our experiments were performed 
without serum and insulin. We have recently shown that insulin acutely improves 
mitochondrial function of L6 and human myoblasts by boosting their coupling efficiency of 
oxidative phosphorylation [22]. Such improvement is annulled in palmitate-exposed cells [22] 
– the deleterious effect of palmitate on coupling efficiency will therefore be likely amplified in 
the presence of insulin. 
In human and L6 myoblasts, palmitate lowers ATP supply for protein synthesis and sodium 
pump activity and, in human cells, it also lowers the supply for DNA/RNA synthesis (Fig. 7). 
Broadly speaking, palmitate could affect ATP turnover in two ways. Skeletal muscle has 
remarkable remodelling ability that allows functional adaptation to environmental stimuli via 
activation of diverse signalling pathways [39]. Paths linking nutrient abundance to cell growth 
are influenced by lipids [40] and it is therefore possible that palmitate down-regulates various 
ATP-consuming processes directly. Alternatively, palmitate may provoke new ATP demand, 
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which reprioritizes the distribution of myoblast ATP supply. The second explanation predicts 
that palmitate affects the reported ATP-consuming processes indirectly, and is consistent 
with the increased proportion of unaccounted ATP supply flux seen after palmitate exposure 
(Figs 6C and 6D). Current efforts are focussed on distinguishing between direct and indirect 
palmitate effects on ATP expenditure, and on identifying the additional palmitate-induced 
ATP demand. Activities that possibly account for uninhibited ATP demand are diverse and 
may include proteolysis, actin/tubulin dynamics and Ca2+-ATPases. 
4.3 Mitochondrial insufficiency debate 
Despite the incomplete mechanistic understanding of the observed NEFA effects on ATP 
turnover, our finding that palmitate causes a dramatic reallocation of ATP supply in skeletal 
muscle (Fig. 7) informs the mitochondrial insufficiency debate. Our data support the slowly 
emerging awareness [8] that mitochondrial involvement in NEFA-induced insulin resistance 
cannot be evaluated in a meaningful way if metabolic control is ignored. Mitochondrial 
capacity per se may indeed be sufficient to cope with the lipid load in the obese state [11], 
but without energy demand this capacity will be inconsequential. This effective mitochondrial 
insufficiency under conditions of low ATP demand will thus allow accumulation of the 
metabolites that are held responsible for NEFA-induced insulin resistance. We assert that 
the current „oxidative capacity‟, „redox signalling‟ and „mitochondrial load‟ models of skeletal 
muscle insulin resistance [8,17] are conceptually the same: lipid metabolites such as 
diacylglycerol and ceramide [13,14], and ROS [15,16] all, but exclusively, accumulate when 
mitochondrial substrate supply outweighs energetic needs and thus the effective oxidative 
phosphorylation capacity. 
4.4 Concluding remarks 
Our findings highlight that mitochondrial involvement in NEFA-induced insulin resistance of 
skeletal muscle is best considered in context of bioenergetic control. We have revealed new 
significant inhibitory effects of palmitate on energy expenditure of rat and human myoblasts. 
We suggest that the palmitate-decreased rate of ATP supply by oxidative phosphorylation is 
partly owing to inhibited ATP turnover (Fig. 8). In other words, a seemingly compromised 
oxidative capacity may have simply arisen from attenuated ATP demand. We believe it may 
be interesting to explore how palmitate affects skeletal muscle ATP expenditure of different 
patients as a variable NEFA-sensitivity of ATP turnover could be responsible for a differential 
propensity of these patients to develop muscle insulin resistance. 
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Highlights 
• Lipotoxic palmitate exposure lowers rate and efficiency of myoblast ATP synthesis. 
• Palmitate decreases the activity of major ATP-consuming processes in myoblasts. 
• Palmitate causes reallocation of ATP supply in human and rat myoblasts. 
